Skip to main content
. 2015 Jun 8;5:11053. doi: 10.1038/srep11053

Table 2. Demographic and clinical information for patients with schizophrenia with and without prominent negative symptoms, and healthy controls.

  Patients with Schizophrenia
Health controls (N = 62) Comparison
  Prominent Negative Symptoms (N = 29) Non-Prominent Negative Symptoms (N = 116)    
Gender (male: female) 20:9 49:67 32:30 X2 = 6.91, df = 2, P = 0.032
Handed (right: left) 27:2 110:6 60:2 X2 = 0.65, df = 2, P = 0.724
Age (year) 22.34 (4.06) 21.69 (3.768) 21.16 (1.89) F = 1.27, df = 2, P = 0.283
Education (year) 11.72 (1.93) 11.94 (2.22) 12.44 (2.18) F = 1.47, df = 2, P = 0.233
IQ estimates a 96.22 (14.16) 102.93 (14.39) 111.52 (13.01) F = 13.67, df = 2, P < 0.001
PANSS
Total score 60.93 (13.91) 42.16 (14.91)   t = 6.14, df = 143, P < 0.001
Negative symptoms 21.79 (5.22) 9.48 (3.51)   t = 15.19, df = 143, P < 0.001
Positive symptoms 12.34 (5.44) 10.98 (5.05)   t = 1.28, df = 143, P = 0.203
General psychopathology 26.79 (6.10) 21.70 (7.79)   t = 3.28, df = 143, P = 0.001
Duration of illness (month) 2.68 (2.10) 3.43 (4.37)   t = -0.90, df = 143, P = 0.372
Simpson-Angus Scale 0.88 (1.59) 0.40 (0.95)   t = 1.55, df = 143, P = 0.132
Barns Akathisia Scale 0.16 (0.45) 0.16 (0.69)   t = 0.04, df = 143, P = 0.972
Abnormal Involuntary Movement Scale 0.00 (0.02) 0.07 (0.46)   t = −0.78, df = 143, P = 0.438

PANSS: Positive and Negative Syndrome Scale; a, Bonferroni post hoc there is no difference between Prominent and Non-Prominent Negative Symptoms groups (P = 0.065).